Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
Follow-Up Questions
Hemagen Diagnostics Inc의 CEO는 누구입니까?
William Hales은 1999부터 회사에 합류한 Hemagen Diagnostics Inc의 Chairman of the Board입니다.
HMGN 주식의 가격 성능은 어떻습니까?
HMGN의 현재 가격은 $0.015이며, 전 거래일에 decreased 0% 하였습니다.
Hemagen Diagnostics Inc의 주요 사업 주제나 업종은 무엇입니까?
Hemagen Diagnostics Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
